Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1989 2
1990 2
1992 1
1993 5
1994 2
1995 1
1996 3
1997 10
1998 5
1999 7
2000 4
2002 3
2003 6
2004 3
2005 3
2006 4
2007 1
2009 2
2011 1
2013 4
2014 1
2015 2
2016 1
2017 1
2018 1
2020 3
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Pilots flying with insulin-treated diabetes.
Russell-Jones DL, Hutchison EJ, Roberts GA. Russell-Jones DL, et al. Diabetes Obes Metab. 2021 Jul;23(7):1439-1444. doi: 10.1111/dom.14375. Epub 2021 Mar 30. Diabetes Obes Metab. 2021. PMID: 33710744 Review.
Hepatoselectivity and the evolution of insulin.
Herring R, Jones RH, Russell-Jones DL. Herring R, et al. Among authors: russell jones dl. Diabetes Obes Metab. 2014 Jan;16(1):1-8. doi: 10.1111/dom.12117. Epub 2013 May 16. Diabetes Obes Metab. 2014. PMID: 23679086 Review.
Insulin detemir and basal insulin therapy.
Russell-Jones DL. Russell-Jones DL. Endocrinol Metab Clin North Am. 2007 Aug;36 Suppl 1:7-13. doi: 10.1016/s0889-8529(07)80003-x. Endocrinol Metab Clin North Am. 2007. PMID: 17881327 Review.
Rosiglitazone or pioglitazone in type 2 diabetes?
de Vries CS, Russell-Jones DL. de Vries CS, et al. Among authors: russell jones dl. BMJ. 2009 Aug 18;339:b3076. doi: 10.1136/bmj.b3076. BMJ. 2009. PMID: 19690344 No abstract available.
The hormonal control of protein metabolism.
Umpleby AM, Russell-Jones DL. Umpleby AM, et al. Among authors: russell jones dl. Baillieres Clin Endocrinol Metab. 1996 Oct;10(4):551-70. doi: 10.1016/s0950-351x(96)80711-7. Baillieres Clin Endocrinol Metab. 1996. PMID: 9022951 Review.
SGLT2 inhibitors in Type 1 diabetes: is this the future?
Herring R, Russell-Jones DL. Herring R, et al. Among authors: russell jones dl. Diabet Med. 2018 Dec;35(12):1642-1643. doi: 10.1111/dme.13791. Diabet Med. 2018. PMID: 30091226 No abstract available.
Insulin-like growth factor-I and diabetes. A review.
Simpson HL, Umpleby AM, Russell-Jones DL. Simpson HL, et al. Among authors: russell jones dl. Growth Horm IGF Res. 1998 Apr;8(2):83-95. doi: 10.1016/s1096-6374(98)80098-1. Growth Horm IGF Res. 1998. PMID: 10987675 Review.
Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.
Herring RA, Shojaee-Moradie F, Garesse R, Stevenage M, Jackson N, Fielding BA, Mendis A, Johnsen S, Umpleby AM, Davies M, Russell-Jones DL. Herring RA, et al. Among authors: russell jones dl. Diabetes Care. 2021 Mar;44(3):e61. doi: 10.2337/dci20-0072. Diabetes Care. 2021. PMID: 33608329 No abstract available.
81 results